Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an efavirenz-based regimen

Margaret Lartey; Kwamena W. Sagoe; Hongmei Yang; Ernest Kenu; Fafa Xexemeku; Joseph Oliver-Commey; Vincent Boima; Markafui Seshie; Augustine Sagoe; Julius A.A. Mingle; Timothy P. Flanigan; Hulin Wu; Awewura Kwara

doi:10.1093/cid/ciq196

Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an efavirenz-based regimen

Margaret Lartey, Kwamena W. Sagoe, Hongmei Yang, Ernest Kenu, Fafa Xexemeku, Joseph Oliver-Commey, Vincent Boima, Markafui Seshie, Augustine Sagoe, Julius A.A. Mingle, Timothy P. Flanigan, Hulin Wu, Awewura Kwara

Department of Medical Microbiology

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

Viral decay rates during efavirenz-based therapy were compared between human immunodeficiency virus (HIV)-infected patients without tuberculosis (n = 40) and those with tuberculosis coinfection who were receiving concurrent antituberculous therapy (n = 34). Phase I and II viral decay rates were similar in the 2 groups (P >.05). Overall, concurrent antituberculous therapy did not reduce the efficacy of the HIV treatment.

Original language	English
Pages (from-to)	547-550
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	52
Issue number	4
DOIs	https://doi.org/10.1093/cid/ciq196
Publication status	Published - 15 Feb 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/ciq196

Cite this

Lartey, M., Sagoe, K. W., Yang, H., Kenu, E., Xexemeku, F., Oliver-Commey, J., Boima, V., Seshie, M., Sagoe, A., Mingle, J. A. A., Flanigan, T. P., Wu, H., & Kwara, A. (2011). Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an efavirenz-based regimen. Clinical Infectious Diseases, 52(4), 547-550. https://doi.org/10.1093/cid/ciq196

@article{d33b443f11c74873a244c5e72abc5009,

title = "Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an efavirenz-based regimen",

abstract = "Viral decay rates during efavirenz-based therapy were compared between human immunodeficiency virus (HIV)-infected patients without tuberculosis (n = 40) and those with tuberculosis coinfection who were receiving concurrent antituberculous therapy (n = 34). Phase I and II viral decay rates were similar in the 2 groups (P >.05). Overall, concurrent antituberculous therapy did not reduce the efficacy of the HIV treatment.",

author = "Margaret Lartey and Sagoe, \{Kwamena W.\} and Hongmei Yang and Ernest Kenu and Fafa Xexemeku and Joseph Oliver-Commey and Vincent Boima and Markafui Seshie and Augustine Sagoe and Mingle, \{Julius A.A.\} and Flanigan, \{Timothy P.\} and Hulin Wu and Awewura Kwara",

year = "2011",

month = feb,

day = "15",

doi = "10.1093/cid/ciq196",

language = "English",

volume = "52",

pages = "547--550",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "4",

}

Lartey, M, Sagoe, KW, Yang, H, Kenu, E, Xexemeku, F, Oliver-Commey, J, Boima, V, Seshie, M, Sagoe, A, Mingle, JAA, Flanigan, TP, Wu, H & Kwara, A 2011, 'Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an efavirenz-based regimen', Clinical Infectious Diseases, vol. 52, no. 4, pp. 547-550. https://doi.org/10.1093/cid/ciq196

TY - JOUR

T1 - Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an efavirenz-based regimen

AU - Lartey, Margaret

AU - Sagoe, Kwamena W.

AU - Yang, Hongmei

AU - Kenu, Ernest

AU - Xexemeku, Fafa

AU - Oliver-Commey, Joseph

AU - Boima, Vincent

AU - Seshie, Markafui

AU - Sagoe, Augustine

AU - Mingle, Julius A.A.

AU - Flanigan, Timothy P.

AU - Wu, Hulin

AU - Kwara, Awewura

PY - 2011/2/15

Y1 - 2011/2/15

N2 - Viral decay rates during efavirenz-based therapy were compared between human immunodeficiency virus (HIV)-infected patients without tuberculosis (n = 40) and those with tuberculosis coinfection who were receiving concurrent antituberculous therapy (n = 34). Phase I and II viral decay rates were similar in the 2 groups (P >.05). Overall, concurrent antituberculous therapy did not reduce the efficacy of the HIV treatment.

AB - Viral decay rates during efavirenz-based therapy were compared between human immunodeficiency virus (HIV)-infected patients without tuberculosis (n = 40) and those with tuberculosis coinfection who were receiving concurrent antituberculous therapy (n = 34). Phase I and II viral decay rates were similar in the 2 groups (P >.05). Overall, concurrent antituberculous therapy did not reduce the efficacy of the HIV treatment.

UR - https://www.scopus.com/pages/publications/79951841208

U2 - 10.1093/cid/ciq196

DO - 10.1093/cid/ciq196

M3 - Article

C2 - 21252140

AN - SCOPUS:79951841208

SN - 1058-4838

VL - 52

SP - 547

EP - 550

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 4

ER -

Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an efavirenz-based regimen

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this